Valuation
- Market cap
- 0
- Revenue TTM
- $0
- Net income TTM
- $-11,620,000
- P/E (trailing)
- 0.00
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- 0.00
Trading
- Volume
- 2,100
- Avg volume
- 95,792
- Day's range
- $0.00 – $0.00
- Shares out
- —
- Stochastic %K
- 0%
- Beta
- 2.96
- Analysts
- —
- Price target
- $4.00
Company profile
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
- Industry
- Shell Companies
- Sector
- Financial Services
- Phone
- 801 214 7800
- Website
- https://www.myrexis.com
- Address
- 600 Fifth Avenue, 2nd Floor, New York, United States
Latest news
No headlines yet.
